Cardio Clinical

Julius Clinical’s proprietary global network dedicated to cardiovascular disease research.

Cardio Clinical is an expansive network of cardiologists and other researchers who are dedicated to developing novel treatments for cardiovascular diseases, including lipid-lowering and stroke prevention trials.

Who we are

The Cardio Clinical network is based on strong historical collaborations with cardiologists from many different hospitals. Cardio Clinical is currently comprised of more than 1,000 hospitals in over 30 countries, providing experienced sites and expert investigators around the globe. Cardio Clinical has been involved in numerous large-scale randomised intervention trials focused on the prevention and treatment of cardiovascular disease. 

What we do

Everyone who is part of the Cardio Clinical network shares the common goal of reducing the burden of cardiovascular disease, the leading cause of death globally over the last 15 years. Our Cardio Clinical network provides access to pioneering researchers and high-level capabilities in cardiovascular trials. That is how Cardio Clinical supports clients to develop treatments that could have a tremendous impact on the cardiological health.

 

Who we are

The Cardio Clinical network is based on strong historical collaborations with cardiologists from many different hospitals. Cardio Clinical is currently comprised of more than 1,000 hospitals in over 30 countries, providing experienced sites and expert investigators around the globe. Cardio Clinical has been involved in numerous large-scale randomised intervention trials focused on the prevention and treatment of cardiovascular disease. 

What we do

Everyone who is part of the Cardio Clinical network shares the common goal of reducing the burden of cardiovascular disease, the leading cause of death globally over the last 15 years. Our Cardio Clinical network provides access to pioneering researchers and high-level capabilities in cardiovascular trials. That is how Cardio Clinical supports clients to develop treatments that could have a tremendous impact on the cardiological health.

 

  • Therap. Area: Infectious diseases
  • Research: Early detection of COVID-19
  • Randomisation: 16,500
  • Period: Ongoing
  • Therap. Area: Diabetes mellitus
  • Research: Metabolic diseases
  • Randomisation: 9,650
  • Period: Ongoing
  • Therap. Area: Cardiovascular diseases
  • Research: Cardiovascular risk factors
  • Randomisation: 2,161
  • Period: Ongoing
  • Therap. Area: Infectious diseases
  • Research: Respiratory syncytial virus (RSV) infections
  • Randomisation: 500
  • Period: Ongoing
  • Therap. Area: Infectious diseases
  • Research: Pneumonia
  • Randomisation: 84,496
  • Period: Completed
  • Therap. Area: Metabolic diseases
  • Research: Type 2 diabetes
  • Randomisation: 137
  • Period: Completed
  • Therap. Area: Gastrointestinal
  • Randomisation: 128
  • Period: Completed
  • Therap. Area: Respiratory diseases
  • Research: Obstructive pulmonary disease
  • Period: Completed
  • Therap. Area: Infectious diseases
  • Research: Influenza A virus
  • Randomisation: 344
  • Period: Completed

Cardio Clinical Team

Cardio Clinical has the experienced people to support your trial.

Martin czakon
Elizabeth liano callahan
Manuel castro cabezas
Vivian de jong

Download

"*" indicates required fields

*

Request for proposal

"*" indicates required fields

*
This field is for validation purposes and should be left unchanged.

Share

Twitter Facebook LinkedIn